Log inAsahi Kasei
Healthcare Materials Division
The Asahi Kasei Healthcare Materials Division offers microcrystalline
cellulose (MCC) for oral solid dosage forms of
pharmaceuticals and nutraceuticals; and hyaluronic acid nanogel for drug delivery system (DDS)
material mainly for
injection formulations of pharmaceuticals.
A noteworthy advantage of our products is their ability to facilitate challenging and/or
innovative formulations of
pharmaceuticals and nutraceuticals that customers are bringing to market.
Products category
About Asahi Kasei
Three business sectors of Asahi Kasei
Asahi Kasei is a diversified Japanese chemical company with over a century of
history.
We operate in the three business sectors of Material, Homes, and Health Care.
Creating for Tomorrow
The commitment of the Asahi Kasei Group:
To do all that we can in every era to help the people of the world make the most of life
and attain fulfillment in living.
Since our founding, we have always been deeply committed to contributing to the
development of society, boldly anticipating the emergence of new needs.
This is what we mean by “Creating for Tomorrow.”
Nobeoka, Miyazaki, Japan, cradle of Asahi Kasei
News
Events
-
Exhibition
Making Pharmaceuticals, Making Nutraceuticals
Date : April 21-22, 2026
Location : Coventry Building Society Arena, UK
Product category : Microcrystalline cellulose (MCC)
Our booth : #833
-
Exhibition
CPHI Japan 2026
Date : April 21-23, 2026
Location : Tokyo Big Sight, Japan
Product category : Microcrystalline cellulose (MCC)
Our booth : #1H-34
-
Conference
17th Global DDF Summit
Date : May 18-20, 2026
Location : Maritim proArte Hotel, Berlin, Germany
Product category : Microcrystalline cellulose (MCC)